full free access: Bisphosphonate Use and the Risk of Subtrochanteric or Femoral Shaft Fractures in Older Women, February 23, 2011 JAMA
Ovarian Cancer and Us
OVARIAN CANCER and US
Ovarian Cancer and Us
Conclusion Among older women, treatment with a
bisphosphonate for more than 5 years was associated with an increased
risk of subtrochanteric
or femoral shaft fractures; however, the absolute
risk of these fractures is low.
0
comments
:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.